scholarly journals Cost-Effectiveness of Cobas® EGFR Mutation Test Versus Sanger Sequencing in the Treatment of Locally Advanced or Metastatic NSCLC: A Payer Perspective in the United Kingdom

2013 ◽  
Vol 16 (7) ◽  
pp. A410 ◽  
Author(s):  
A. Towse ◽  
M. Gavaghan ◽  
T. Strunz-McKendry ◽  
S. Garfield ◽  
N. Poulios
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Sanger Sequencing ◽  
Egfr Mutation ◽  
Locally Advanced ◽  
Metastatic Nsclc ◽  
The United Kingdom ◽  
Payer Perspective

scholarly journals Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0175920 ◽  
Author(s):  
Jordan Amdahl ◽  
Jose Diaz ◽  
Arati Sharma ◽  
Jinhee Park ◽  
David Chandiwana ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
United Kingdom ◽  
Cost Effectiveness ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
The United Kingdom
Sign in / Sign up

Export Citation Format

Share Document